New patent for Slayback Pharma drug VIVIMUSTA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for VIVIMUSTA
Annual Drug Patent Expirations for VIVIMUSTA

Vivimusta is a drug marketed by Slayback Pharma Llc and is included in one NDA. It is available from one supplier.

The generic ingredient in VIVIMUSTA is bendamustine hydrochloride. One supplier is listed for this compound. Additional details are available on the bendamustine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top